8 February 2016 - U.S. based health insurers Cigna Corporation and Aetna Inc. have struck deals with Novartis for a performance-based price for the Swiss drug-maker's new heart drug, Entresto, the companies said on Monday.

For more details, go to: http://www.reuters.com/article/cigna-novartis-drugpricing-idUSL2N15N1ZB